SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $404,000 | +2.3% | 27,000 | -16.8% | 0.02% | -12.0% |
Q1 2016 | $395,000 | -11.2% | 32,461 | +16.1% | 0.02% | +13.6% |
Q4 2015 | $445,000 | -56.4% | 27,960 | -36.3% | 0.02% | -46.3% |
Q1 2015 | $1,021,000 | +228.3% | 43,904 | +265.3% | 0.04% | +192.9% |
Q2 2014 | $311,000 | +15.2% | 12,018 | +13.1% | 0.01% | -33.3% |
Q4 2013 | $270,000 | – | 10,627 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |